Patten Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Patten Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,000	Closed	-$47K	–	660
2016 Q4	$47K	Sell	2,000 -1,000	-33%	-$12K	0.02%	314
2016 Q3	$39.2K	Buy	+3,000	New	+$30.1K	0.02%	337

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Patten Group's ARIA Position: Q1 2017 in Review

Patten Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 2,000 shares — an estimated $47K sold.

Patten Group first reported a position in ARIA in Q3 2016 and held it in 2 quarters. The position peaked at $47K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Patten Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Patten Group sold 2,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $47K.
Patten Group first reported a position in Ariad Pharmaceuticals Inc in Q3 2016 and held it in 2 quarters.
Patten Group's Ariad Pharmaceuticals Inc position peaked at $47K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Patten Group's 13F filing for Q1 2017, filed 31 May 2017.